Antengene

Antengene's reported carbon emissions

Antengene, a pharmaceutical preparation manufacturer headquartered in China, has reported its carbon emissions for the years 2020 through 2023. In 2023, Antengene's total greenhouse gas (GHG) emissions were approximately 1,169,980 kg CO2e. This comprised about 45,220 kg CO2e of Scope 1 emissions and approximately 1,124,760 kg CO2e of Scope 2 emissions. The company did not report Scope 3 emissions for this year. For 2022, Antengene's total GHG emissions were approximately 1,613,260 kg CO2e. Scope 1 emissions accounted for about 551,320 kg CO2e, and Scope 2 emissions were approximately 1,061,940 kg CO2e. Scope 3 emissions were not disclosed. In 2021, the company reported total emissions of around 994,380 kg CO2e, with Scope 1 emissions at approximately 27,080 kg CO2e and Scope 2 emissions at about 967,300 kg CO2e. Scope 3 emissions were not included in this report. Antengene's GHG emissions in 2020 were approximately 278,470 kg CO2e, made up of about 27,080 kg CO2e of Scope 1 emissions and approximately 251,390 kg CO2e of Scope 2 emissions. Scope 3 emissions were not reported. The company has published information regarding its GHG emission intensity per square metre and per employee in its sustainability reports. As of the provided data, Antengene has not disclosed specific company-wide absolute reduction targets or commitments to climate initiatives such as the Science Based Targets initiative (SBTi) or the Climate Pledge. Its disclosures currently focus on Scope 1 and Scope 2 emissions.